Examines growth mispricing in equity markets, indicating a robust predictive framework for investors.
The Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in. It is a falsifiable, filings-based measure of equity mispricing, and on the full S&P 500 it predicts five-year stock returns where the Margin of Safety — value investing's 90-year-old cornerstone — does not. Precisely, the Brina Gap formula is a single difference: Brina Gap = (ROIC × Reinvestment Rate) − Market-Implied Growth Rate. The first term is the firm's fundamental growth ceiling — the growth its return on invested capital (ROIC) and reinvestment can finance; the second is the market-implied growth rate, the growth already priced into its enterprise value and recovered from a reverse discounted-cash-flow. Both terms come directly from public financial statements, so the Gap compares two externally verifiable quantities rather than an analyst's private valuation — making it testable and falsifiable, unlike the Margin of Safety, whose intrinsic-value input depends on the observer. Tested across the full S&P 500 from 2010 to 2024 (6,428 firm-years; 1,137 with completed five-year return windows), the results are sharp. The Margin of Safety — in the owner-earnings-DCF form investors actually apply — fails to predict returns: 48.2% directional accuracy, no better than chance (p=0.94). The Brina Gap predicts: a modest but highly significant edge (52.6% overall, rising to 55.1% on strong signals; p=0.0003), sharpening to a 67% hit rate in identifying “value traps” and 59% on overvalued “expensive hype” stocks. Most tellingly, on the firm-years where the two signals disagree, the Brina Gap is right 55% of the time and the Margin of Safety only 45% — direct evidence that the Gap carries information the price-versus-value comparison misses. The framework's edge is sharpest as a negative screen — strong at flagging overvalued losers, weaker at picking winners on the broad universe — and concentrates in sectors where its steady-state assumption holds (Utilities 79%): a bounded, pre-registered scope, not a hidden weakness. A second finding identifies reinvestment quality — ROIC and the reinvestment rate — as the load-bearing signal in detecting growth mispricing: a two-input measure that outperforms the multi-input discounted-cash-flow machinery it replaces. The pre-registration, full panel dataset, corporate-event database, and complete replication pipeline are published openly, so that every result can be independently reproduced or refuted. JEL Classification: G11, G12, G14 | Keywords: equity valuation, Brina Gap, growth mispricing, reverse DCF, ROIC, reinvestment rate, market-implied growth rate, margin of safety, Brina Matrix, valuation matrix, value trap, owner earnings, value investing, intrinsic value, fundamental analysis
No takes yet. Share an insight, caveat, or question.
Fabio Brina (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: